An approach for the transition from systemic immunosuppressants to dupilumab.

de Wijs, L E M; Thyssen, J P; Vestergaard, C; Thio, H B; Kunkeler, A C M; Biedermann, T; Hijnen, D J

de Wijs, L E M; Thyssen, J P; Vestergaard, C; Thio, H B; Kunkeler, A C M; Biedermann, T; Hijnen, D J.

Afiliação

de Wijs LEM; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Thyssen JP; Department of Dermatology and Allergy, Herlev-Gentofte Hospital, University of Copenhagen, Denmark.
Vestergaard C; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Thio HB; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Kunkeler ACM; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Biedermann T; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.
Hijnen DJ; Department of Dermatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

J Eur Acad Dermatol Venereol ; 35(3): e221-e223, 2021 Mar.

Article em En | MEDLINE | ID: mdl-32920932

Assuntos

Dermatite Atópica; Imunossupressores; Anticorpos Monoclonais Humanizados; Dermatite Atópica/tratamento farmacológico; Humanos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatite Atópica / Imunossupressores Limite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google